AHCO vs ALNY · P/E 16, rev $1.42B vs P/E 76, rev $1.29B
Adapthealth Corp (AHCO) versus Alnylam Pharmaceuticals Inc (ALNY) — a side-by-side from cached financials, not a winner call.
Adapthealth Corp (AHCO) is a medical devices company listed on US.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Latest reported AHCO revenue for 2026-06-30 was $1.42B. Net income was -$150.0M. Revenue was up 73.2% from 2026-03-31 to 2026-06-30. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Not investment advice. Open the AHCO and ALNY stock pages for the full models.
Not investment advice.